Overview
Researchers planning incretin-pathway investigation can buy Semaglutide research peptide from Advanced Peptide Science at 99%+ HPLC-verified purity. Semaglutide is a 31-amino-acid GLP-1 receptor agonist (94% homology to native human GLP-1) extensively investigated in preclinical insulin secretion, CNS appetite regulation, and cardiovascular research models.
Bacteriostatic Water (BAC Water) 30ml is required for reconstitution of this lyophilized compound. Available separately: Bacteriostatic Water 30ml.
Research Background
Semaglutide emerged from second-generation GLP-1 analogue research lineages building on Liraglutide. The structural modification of α-aminoisobutyric acid (Aib) at position 8 confers DPP-4 protease resistance, while the C18 fatty-diacid linker attached via Lys26 enables strong albumin binding and a substantially extended preclinical half-life relative to native GLP-1. The compound has become a comparative standard in metabolic peptide research.
Mechanism of Action (Research Context)
Mechanism research investigates Semaglutide’s high-affinity binding at the GLP-1 receptor (GLP-1R), a class B GPCR coupled to Gs/cAMP signalling. Downstream pathways under investigation include glucose-dependent insulin secretion from pancreatic beta cells, glucagon suppression, delayed gastric emptying, and central appetite-circuit modulation via GLP-1R expression in the arcuate nucleus, area postrema, and nucleus tractus solitarius.
Research Applications
- GLP-1 receptor pharmacology and signalling cascade research
- Glucose-dependent insulin secretion and beta-cell function studies
- CNS appetite-circuit modulation in preclinical models
- Cardiovascular risk marker investigation in metabolic models
- Comparative incretin research vs Tirzepatide and Retatrutide
Compound Specifications
| Molecular Weight | 4113.6 Da |
| Sequence / Composition | 31-amino-acid GLP-1 analogue (94% homology to human GLP-1) with C18 fatty-diacid linker |
| Appearance | White lyophilized powder |
| Purity | ≥ 99% (HPLC verified) |
| Storage | -20 °C, protect from light |
| Format | Lyophilized powder in sterile vial |
Quality Assurance
Each batch is independently verified by third-party analytical laboratories. Certificates of Analysis confirming ≥99% purity via HPLC are available on request at research@advancedpeptidescience.com.
Research Use Only. For Research Use Only. Not for human consumption. Not intended to diagnose, treat, cure, or prevent any disease. By purchasing you confirm research-only intent. These products have not been evaluated by the FDA.
Frequently Asked Questions
Buy semaglutide research peptide 2026 USA — what purity?
Advanced Peptide Science supplies Semaglutide at 99%+ HPLC-verified purity with batch-specific COA available on request. All compounds ship from the United States to qualified research laboratories.
Semaglutide vs Tirzepatide research peptide — what is the difference?
Semaglutide is a GLP-1 mono-agonist (4113.6 Da, 31 amino acids); Tirzepatide is a GLP-1/GIP dual agonist (4813.5 Da, 39 amino acids). Research investigates the relative contribution of GIP receptor co-engagement to combined incretin signalling.
Is Semaglutide approved for human use?
Advanced Peptide Science supplies Semaglutide exclusively for in vitro and in vivo scientific research. Not for human consumption. Research use only.


